Akers Biosciences Inc. Daily Stock Analysis

Daily Stock Analysis, AKER, Akers Biosciences Inc, priceseries

Akers Biosciences Inc. Daily Stock Analysis
Stock Information
Open
6.35
Close
4.95
High
7.89
Low
4.60
Previous Close
4.46
Daily Price Gain
0.49
YTD High
8.85
YTD High Date
Apr 7, 2020
YTD Low
0.01
YTD Low Date
Jun 12, 2013
YTD Price Change
4.77
YTD Gain
2650.00%
52 Week High
7.89
52 Week High Date
Apr 20, 2021
52 Week Low
2.40
52 Week Low Date
Apr 16, 2021
52 Week Price Change
2.30
52 Week Gain
86.79%
Recent priceSeries Trade Signals

These are sample algorithmic trades based on actual market data.

Trade Type
Entry Date
Entry Price
Exit Date
Exit Price
Trade Hold Time
Gain
Trade Record
LONG
Mar 22. 2017
1.25
Apr 3. 2017
1.60
8 Trading Days
28.13%
Link
LONG
Dec 27. 2018
1.00
Jan 22. 2019
1.34
16 Trading Days
34.15%
Link
LONG
Nov 27. 2019
6.51
Dec 2. 2019
7.25
2 Trading Days
11.44%
Link
LONG
Apr 6. 2020
4.69
Apr 9. 2020
5.01
3 Trading Days
6.72%
Link
LONG
Jul 16. 2020
4.29
Jul 27. 2020
4.63
7 Trading Days
7.95%
Link
LONG
Jul 30. 2020
5.49
Jul 31. 2020
5.87
1 Trading Days
6.92%
Link
LONG
Jan 4. 2021
2.10
Jan 28. 2021
2.64
17 Trading Days
25.91%
Link
LONG
Feb 4. 2021
2.89
Feb 19. 2021
3.55
10 Trading Days
22.90%
Link
Company Information
Stock Symbol
AKER
Exchange
NasdaqCM
Company URL
http://www.akersbio.com
Company Phone
856-848-8698
CEO
John J. Gormally
Headquarters
New Jersey
Business Address
201 GROVE RD, THOROFARE, NJ 08086
Sector
Equity
Industry Category
Health Services
Industry Group
Medical Instruments & Supplies
CIK
0001321834
About

Akers Biosciences, Inc. is the developer of health information technologies. It engages in the developing, manufacturing, and supplying screening and testing products to deliver healthcare information to consumers and healthcare providers. Its products include clinical diagnostics, safety diagnostics, wellness products, and tests in development. The company was founded by Raymond Francis Akers, Jr. and Raymond F. Akers, Sr. on March 8, 1989 and is headquartered in West Deptford, NJ.

Description

Akers Biosciences, Inc., together with its subsidiaries, focuses on the development and sale of disposable diagnostic testing devices to facilitate time sensitive therapeutic decisions in the United States and internationally. The company offers BreathScan/CHUBE, a disposable breath alcohol detector; BreathScan PRO, a quantitative breath alcohol detection system; METRON, a disposable breath ketone device to monitor weight loss; VIVO for the measurement of biological markers for oxidative stress that relates to cellular damage non-invasively; PIFA Heparin/PF4 and PIFA PLUSS PF4 rapid assay for detecting heparin-induced thrombocytopenia antibodies; seraSTAT, a device to separate rapid blood cells; and Tri-Cholesterol Check' to estimate high density lipoprotein cholesterol and low density lipo protein levels. It is also involved in the development of Breath Ketone Check', a disposable breath ketone device for diabetic monitoring, and management of senile dementia and alzheimers disease patients; Breath PulmoHealth Check', a suite of breath tests for biomarkers indicating asthma, chronic obstructive pulmonary disease, and lung cancer; and PIFA PLUSS that provides rapid tests for various infectious diseases. The company was founded in 1989 and is headquartered in Thorofare, New Jersey.

TCHANNELS® is a Registered Trademark with USPTO

Some images used on this site have been taken from Unsplash

Legal Information

Useful Links

Contact Us

PO Box 2574, Sunnyvale
California 94087-0574, USA
Phone: 408-940-5056
Email: Click to send us an Email

Risks of Algorithmic Trading: Before investing please read our disclosure on Risks of Algorithmic Trading.

DISCLAIMER All investments entail inherent risk. This research seeks to assist investors in determining when to buy and when to sell to attempt to maximize profits or minimize losses. All final investment decisions are yours and as a result you could make or lose money. priceSeries.com, its employees and/or its affiliates and family members may from time to time take positions in the open market or otherwise with respect to the securities discussed. priceSeries.com, its employees and/or affiliates do not have stock ownership equal to or greater than 1% of the outstanding stock of the covered company nor does any employee of priceSeries.com sit on the Board of Directors of any covered company. priceSeries.com is not a broker/dealer, and the firm does not underwrite securities, manage assets or perform investment banking activities. The statements made herein include information obtained from sources believed to be reliable, but no independent verification has been made and we do not guarantee its accuracy or completeness.

U.S. Government Required Disclaimer - Commodity Futures Trading Commission
Futures and Options trading has large potential rewards, but also large potential risk. You must be aware of the risks and be willing to accept them in order to invest in the futures and options markets. Don't trade with money you can't afford to lose. This is neither a solicitation nor an offer to Buy/Sell futures or options. No representation is being made that any account will or is likely to achieve profits or losses similar to those discussed on this web site. The past performance of any trading system or methodology is not necessarily indicative of future results.

CFTC RULE 4.41 - HYPOTHETICAL OR SIMULATED PERFORMANCE RESULTS HAVE CERTAIN LIMITATIONS. UNLIKE AN ACTUAL PERFORMANCE RECORD, SIMULATED RESULTS DO NOT REPRESENT ACTUAL TRADING. ALSO, SINCE THE TRADES HAVE NOT BEEN EXECUTED, THE RESULTS MAY HAVE UNDER-OR-OVER COMPENSATED FOR THE IMPACT, IF ANY, OF CERTAIN MARKET FACTORS, SUCH AS LACK OF LIQUIDITY. SIMULATED TRADING PROGRAMS IN GENERAL ARE ALSO SUBJECT TO THE FACT THAT THEY ARE DESIGNED WITH THE BENEFIT OF HINDSIGHT. NO REPRESENTATION IS BEING MADE THAT ANY ACCOUNT WILL OR IS LIKELY TO ACHIEVE PROFIT OR LOSSES SIMILAR TO THOSE SHOWN.

2016 © priceSeries.com All Rights Reserved. Privacy Policy | Subscriber Agreement | Risks of Algorithmic Trading